MRKR MARKER THERAPEUTICS INC Other Situations 8-K Filing 2024 - Clinical Presentation at Medical Conference Marker Therapeutics, Inc. announced that Dr. Geoffrey Shouse presented clinical observations from the APOLLO study at a medical conference, reporting positive results after MT-601 treatment.Get access to all SEC 8-K filings of the MARKER THERAPEUTICS INC